Skip to main content
Top

Current Diabetes Reports

Issue 4/2016

Content (8 Articles)

Economics and Policy in Diabetes (ES Huang and A Baig, Section Editors)

The Affordable Care Act and Diabetes Diagnosis and Care: Exploring the Potential Impacts

Rebecca Myerson, Neda Laiteerapong

Microvascular Complications—Nephropathy (AP Maxwell, Section Editor)

Has RAAS Blockade Reached Its Limits in the Treatment of Diabetic Nephropathy?

Collen Majewski, George L. Bakris

Other Forms of Diabetes (JJ Nolan, Section Editor)

Diabetes and Menopause

Carrie A. Karvonen-Gutierrez, Sung Kyun Park, Catherine Kim

Diabetes and Pregnancy (CJ Homko, Section Editor)

Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus

Tove Lekva, Errol R. Norwitz, Pål Aukrust, Thor Ueland

Diabetes and Pregnancy (CJ Homko, Section Editor)

Bariatric Surgery and the Pregnancy Complicated by Gestational Diabetes

Kent Willis, Charlotte Alexander, Eyal Sheiner

Diabetes and Pregnancy (CJ Homko, Section Editor)

Role of Medical Nutrition Therapy in the Management of Gestational Diabetes Mellitus

Cristina Moreno-Castilla, Didac Mauricio, Marta Hernandez

Hospital Management of Diabetes (GE Umpierrez, Section Editor)

Perioperative Glycemic Management of Patients Undergoing Bariatric Surgery

David Rometo, Mary Korytkowski

Hospital Management of Diabetes (GE Umpierrez, Section Editor)

Intensive Glycemic Control in Cardiac Surgery

Lillian L. Tsai, Hanna A. Jensen, Vinod H. Thourani

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine